ABSI Absci: Earnings growth forecast for next year

Absci Corporation (ABSI) - corporate logo

Absci integrates generative AI and robotics for instantaneous digital antibody design, eliminating routine labor. This time-series projection of future earnings per share growth on the GURU.Markets chart reflects expectation dynamics, where the value 7.20 describes the current level. Absci is implementing innovative de novo drug design while simultaneously expanding its computing power and modernizing its high-tech laboratories.

ABSI: Absci Corp. Net earnings per share growth forecast for next year 07/04/2022 - 11/10/2026

ABSI (absci.com): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Price Absci Corp.|ABSI - Analyst Median Target
- company stock capitalization data:
Market Capitalization Absci|ABSI - Enterprise Value
- book capitalization indicators:
Book Value per Share Absci|ABSI - Company Book Value|Market Value to Book Value Ratio absci.com|ABSI - Company Total Asset Base
- debt and liquidity details:
Total Debt to Capital Absci|ABSI - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Absci Corporation|ABSI - Company Total Debt Obligations|Debt to Book Value Absci|ABSI - Amount of Long-Term Liabilities|Company Current Liabilities Absci|Quick Liquidity absci.com
- earnings and valuation multiples information:
ABSI - Net Income|Projected Future Earnings Absci|ABSI - Market Cap to Earnings|Forward P/E Multiple Absci|ABSI - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Absci|ABSI - Operating profit EBITDA|Net earnings per share (EPS TTM) Absci|ABSI - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months absci.com|ABSI - Expected net earnings per share growth this year|Earnings growth forecast for next year Absci
Initial company analysis:Absci Corp.
Finished products of absci.com

The integration of the Absci (ABSI) AI platform into drug development in collaboration with Merck and AstraZeneca is accelerating the commercialization of antibodies. By analyzing analyst benchmarks for 12-month EPS growth, investors can track the trend of expected net income for the coming year. This metric mathematically captures changes in earnings forecasts, allowing a distinction between genuine fundamental stability and market noise. This indicator defines the security's status as a high-tech asset dependent on the pace of partnership implementation.

Direct competitors

VEEV (Veeva Systems Inc) - Earnings growth forecast for next year|Doximity Network (DOCS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year HQY|Earnings growth forecast for next year waystar.com (WAY)|Earnings growth forecast for next year CRVL (CorVel)|Privia Health Group, Inc. - Net earnings per share growth forecast for next year|HURN - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Certara Software CERT|OMCL: Earnings growth forecast for next year|GDRX - Consensus forecast of earnings per share growth for next year|SDGR (Schrödinger) - Earnings growth forecast for next year|Phreesia Inc (PHR) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year OMDA (Omada Health Corp)|Projected earnings per share increase next year EVH|HealthStream, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year DH|CCSI - Net earnings per share growth forecast for next year|agilon health, inc. (AGL) - Expected earnings per share growth for next year|SY: Earnings growth forecast for next year|Expected net earnings per share growth next year NRC Health Inc. (NRC)|SPOK (Spok Holdings, Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year OPRX (optimizerx.com)|Earnings growth forecast for next year TBRG|Earnings growth forecast for next year Simulations Plus Inc (SLP)|Earnings growth forecast for next year SOPH (SOPHiA GENETICS)|Health Catalyst Inc - Net earnings per share growth forecast for next year|CCLD - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Research Solutions Inc. RSSS|DLHC: Earnings growth forecast for next year|Expected earnings per share growth for next year OneMedNet|SCNX (Scienture Holdings Inc.) - Earnings growth forecast for next year|Healthcare Triangle Corporation (HCTI) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year ISPC|Earnings growth forecast for next year bullfrogai.com (BFRG)|Earnings growth forecast for next year WORX (SCWorx)|MSP Recovery Inc. - Net earnings per share growth forecast for next year|ICCT - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year TRxADE Health Corp MEDS|ORGS: Earnings growth forecast for next year|RCM - Consensus forecast of earnings per share growth for next year|SHCR (Sharecare) - Earnings growth forecast for next year|Streamline Health Solutions, Inc. (STRM) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SYRA (Syra Health Corporation)|Projected earnings per share increase next year AMEH|Model N, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year NXGN